These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28405500)

  • 1. Zoledronate can induce colorectal cancer microenvironment expressing BTN3A1 to stimulate effector γδ T cells with antitumor activity.
    Zocchi MR; Costa D; Venè R; Tosetti F; Ferrari N; Minghelli S; Benelli R; Scabini S; Romairone E; Catellani S; Profumo A; Poggi A
    Oncoimmunology; 2017; 6(3):e1278099. PubMed ID: 28405500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.
    Rhodes DA; Chen HC; Price AJ; Keeble AH; Davey MS; James LC; Eberl M; Trowsdale J
    J Immunol; 2015 Mar; 194(5):2390-8. PubMed ID: 25637025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Priming of Colorectal Tumor-Associated Fibroblasts with Zoledronic Acid Conjugated to the Anti-Epidermal Growth Factor Receptor Antibody Cetuximab Elicits Anti-Tumor Vδ2 T Lymphocytes.
    Fernandez JLC; Benelli R; Costa D; Campioli A; Tavella S; Zocchi MR; Poggi A
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.
    Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters.
    Rhodes DA; Chen HC; Williamson JC; Hill A; Yuan J; Smith S; Rhodes H; Trowsdale J; Lehner PJ; Herrmann T; Eberl M
    Front Immunol; 2018; 9():662. PubMed ID: 29670629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells.
    Gu S; Nawrocka W; Adams EJ
    Front Immunol; 2014; 5():688. PubMed ID: 25657647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Vγ9Vδ2 T Cell Antigen Receptor and Butyrophilin-3 A1: Models of Interaction, the Possibility of Co-Evolution, and the Case of Dendritic Epidermal T Cells.
    Karunakaran MM; Herrmann T
    Front Immunol; 2014; 5():648. PubMed ID: 25566259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
    Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
    Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Division of labor and cooperation between different butyrophilin proteins controls phosphoantigen-mediated activation of human γδ T cells.
    Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
    Res Sq; 2023 Feb; ():. PubMed ID: 36824912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
    Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
    J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.
    Salim M; Knowles TJ; Baker AT; Davey MS; Jeeves M; Sridhar P; Wilkie J; Willcox CR; Kadri H; Taher TE; Vantourout P; Hayday A; Mehellou Y; Mohammed F; Willcox BE
    ACS Chem Biol; 2017 Oct; 12(10):2631-2643. PubMed ID: 28862425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.
    Boutin L; Scotet E
    Front Immunol; 2018; 9():828. PubMed ID: 29731756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.
    Harly C; Guillaume Y; Nedellec S; Peigné CM; Mönkkönen H; Mönkkönen J; Li J; Kuball J; Adams EJ; Netzer S; Déchanet-Merville J; Léger A; Herrmann T; Breathnach R; Olive D; Bonneville M; Scotet E
    Blood; 2012 Sep; 120(11):2269-79. PubMed ID: 22767497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells.
    Sandstrom A; Peigné CM; Léger A; Crooks JE; Konczak F; Gesnel MC; Breathnach R; Bonneville M; Scotet E; Adams EJ
    Immunity; 2014 Apr; 40(4):490-500. PubMed ID: 24703779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing.
    Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
    Nat Commun; 2023 Nov; 14(1):7617. PubMed ID: 37993425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Butyrophilin 3A1 (BTN3A1) enhances activation and proliferation of human peripheral blood Vγ9Vδ2 T cells induced by MTB-HAg].
    Tang J; Sun J; Zha C; Chang J; Hu K; Fang Q; Chen Y; Chen J; Li B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):680-686. PubMed ID: 32958123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6.
    Riaño F; Karunakaran MM; Starick L; Li J; Scholz CJ; Kunzmann V; Olive D; Amslinger S; Herrmann T
    Eur J Immunol; 2014 Sep; 44(9):2571-6. PubMed ID: 24890657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells.
    Harly C; Peigné CM; Scotet E
    Front Immunol; 2014; 5():657. PubMed ID: 25601861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression level of BTN3A1 on the surface of CD14
    Tomogane M; Omura M; Sano Y; Shimizu D; Toda Y; Hosogi S; Kimura S; Ashihara E
    Biochem Biophys Res Commun; 2022 Jan; 588():47-54. PubMed ID: 34952469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
    Varesano S; Zocchi MR; Poggi A
    Front Immunol; 2018; 9():998. PubMed ID: 29867975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.